期刊文献+

急性呼吸窘迫综合征患者单核细胞人类白细胞抗原DR表达及其与预后的关系 被引量:3

Monocyte human leukocyte antigen-DR expression and the prognosis in patients with acute respiratory distress syndrome
在线阅读 下载PDF
导出
摘要 目的探讨急性呼吸窘迫综合征(ARDS)患者单核细胞人类白细胞抗原DR(HLA-DR)表达及其与预后的关系。方法2004年7月至2005年6月收住东南大学附属中大医院ICU的76例ARDS患者纳入观察。ARDS确诊当天(第1天)及确诊后第7天抽取外周血,应用流式细胞仪检测T淋巴细胞亚群占淋巴细胞百分比、单核细胞HLA-DR表达以及淋巴细胞凋亡。记录患者年龄、性别、导致ARDS的原因,及ARDS确诊当天急性生理和慢性健康(APACHE)Ⅱ评分、心率、呼吸频率、平均动脉压、氧合指数、动脉血pH、动脉血乳酸、外周血血红蛋白浓度、血小板和白细胞计数以及器官功能衰竭个数。以住院28d病死率为预后判定标准。结果与生存组比较,死亡组患者在ARDS第1天和第7天的单核细胞HLA-DR表达均无明显差异。死亡组患者ARDS第7天的单核细胞HLA-DR表达明显低于ARDS第1天。ARDS第1天HLA-DR≤30%的患者生存时间明显低于HLA-DR>30%患者。ARDS第1天HLA-DR≤30%的患者的28d病死率为67%,有高于HLA-DR>30%患者(42%)的趋势,但差异无统计学意义。以ARDS第1天HLA-DR≤30%作为判断患者死亡指标,其灵敏度为97%,但特异度仅为17%。以ARDS第1天单核细胞HLA-DR表达判断患者预后的ROC曲线下面积为0.553(P=0.618),以患者第1天和第7天单核细胞HLA-DR表达变化判断预后的ROC曲线下面积为0.830(P<0.01)。患者ARDS第1天及第7天HLA-DR表达与APACHEⅡ评分和器官功能衰竭数均无相关性。严重感染导致的ARDS患者的生存时间明显低于其他原因导致的ARDS患者。结论单核细胞HLA-DR≤30%可提示ARDS患者预后不良,HLA-DR表达动态下降对预后判断也具有一定价值。 Objective To investigate the relationship between monocyte human leukocyte antigen-DR (HLA- DR) expression on peripheral monocytes and the prognosis in patients with acute respiratory distress syndrome (ARDS). Methods Seventy-six patients with ARDS admitted to this hospital between July 2004 and June 2005 were included in this study. After the diagnosis of ARDS, monocytes HLA-DR expression and immunophenotype of lymphocyte (CD3, CD4, CD8) were measured on the 1^st and the 7th days of ARDS using flow cytometry. On the 1^st day of ARDS, the following variables were recorded: age, sex, Acute Physiology and Chronic Health Evaluation (A- PACHE) Ⅱ score, heart rate, respiratory rate, mean arterial pressure, PaO2/FiO2, arterial blood pH and lactate, peripheral blood haemoglobin, platelet and,leukocyte counts and the number of organs with function failure. The pa- t tients were divided into survivors and non-survivors according to whether they died within the 28 day period following the onset of ADRS. Results The monocyte HLA-DR expression on the 1^st and the 7^th days of ARDS were not different between survivors and non-survivors. In the non-survivors, the monocyte HLA-DR expression on the 7^th day of ARDS was significantly lower than that on the 1^st day. The survival time in patients with the 1^st day HLA-DR〉30% was much longer than that in patients with the 1^st day HLA-DR ≤ 30G. The 28 day mortality of patients with the 1^st day HLA-DR ≤30G was 6%, which was slightly higher than that of patients with the 1^st day HLA DR 〉30% (42%). Taking the 1^st day monocytes HI.A-DR expression ≤30% as a predictor of death, its sensitivity was 97% and specificity was 17%. The area under ROC curve which predicted prognosis using 1^st day HLA-DR was only 0. 553 (P = 0. 618), while the area under ROC curve which predicted prognosis using the changes of HLA DR expression on the 1^st day and the 7^th day was 0. 830 (P 〈 0.01). No correlation was found between expression of HLA DR on 1^st day and 7^th day and APACHE Ⅱ score or number of organs with function failure. The survival time of severe inlet tion-induced ARDS patients were lower than that of nowinfection induced ARDS patients. Conclusion Monocyte HLA-DR expression ≤ 30% points to poor prognosis. The decline of HLA-DR expression may be a useful prognostic marker of outcome.
出处 《中华老年多器官疾病杂志》 2009年第2期127-132,共6页 Chinese Journal of Multiple Organ Diseases in the Elderly
基金 江苏省科技发展计划(BS2007048) 江苏省医学领军人才基金(苏卫科教[2006]50号)
关键词 急性呼吸窘迫综合征 预后 患者 单核细胞人类白细胞抗原DR acute respiratory distress syndrome prognosis
作者简介 刘玲,女,1977年11月生,在读博士研究生,主治医师 通讯作者:邱海波,E—mail:haiboq2000@yahoo.com.cn,Tel:025—83272200
  • 相关文献

参考文献12

  • 1Cheadle WG, Hershman MJ, Wellhausen SR, et al. HLA-DR antigen expression on peripheral blood mon ocytes correlates with surgical infection. Am J Surg, 1991, 161: 638-645.
  • 2Schinkel C, Seendtner R, Zimmer S, et al. Functional analysis of monocyte subsets in surgical sepsis. J Trauma, 1998, 44: 743-749.
  • 3Decke WD, HEflich C, Davis KA, et al. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem, 2005, 51: 2341-2347.
  • 4Saenz JJ, Izure JJ, Manrique A, et al. Early prognosis in severe sepsis via analyzing the monoeyte immunophenotype. Intensive Care Med, 2001, 27: 970-977.
  • 5Oczenski W, Krenn H, Jilch R, et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med, 2003, 29: 1253-1257.
  • 6Perry SE, Mostafa SM, Wenstone R, et al. Is low monocyte HLA-DR expression helpful to predict out- come in severe sepsis? Intensive Care Med, 2003, 29: 1245-1252.
  • 7Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 1994, 149(3 Pt 1): 818-824.
  • 8Bone RC. Sir Isaac Newton. Sepsis, SIRS, and CARS. Crit Care Med, 1996, 24:1125-1128.
  • 9HEflich C, DEcke WD, Meisel C, et al. Regulatory immunodeficieney and monocyte deactivation assessment based on HLA-DR expression. Clin Appl Immunol Rev, 2002, 2: 337-344.
  • 10Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen DR expression predicts mortality in septic shock. Intensive Care Med, 2006, 32: 1175-1183.

二级参考文献15

共引文献7

同被引文献15

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部